Cellectis - ADR

NASDAQ:CLLS   3:59:56 PM EDT
15.47
+0.67 (+4.53%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)703.31M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$11.1 Million
Adjusted EPS-$0.73
See more estimates
10-Day MA$15.09
50-Day MA$16.29
200-Day MA$21.19
See more pivots

Cellectis - ADR Stock, NASDAQ:CLLS

8, rue de la Croix Jarry, Paris, Ile-de-France 75013
France
Phone: +33.1.81.69.16.00
Number of Employees: 281

Description

Cellectis SA engages as a biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells. It offers Gene editing and Immuno-oncology. The company was founded by David J. Sourdive and Andr?© Choulika on February 20, 1999 and is headquartered in Paris, France.